Page 9 - Read Online
P. 9

48         Long-term survival of occult hepatitis B associated hepatocellular carcinoma following surgery and antiviral
                       therapy
                       Tina Boortalary, Ernest Rosato, Christopher Roth, Xiangdong David Ren, Selena Y. Lin, Hie-Won Hann
                       Hepatoma Res 2020;6:48  http://dx.doi.org/10.20517/2394-5079.2020.38


          49         Combined transarterial chemoembolization and stereotactic body radiation therapy as a bridge therapy to
                       liver transplant for hepatocellular carcinoma
                       Bui Quang Bieu, Nguyen Dinh Chau, Nguyen Xuan Kien, Le Van Thanh, Vu Van Quang, Thai Doan Ky, Nguyen
                       Tien Thinh, Mai Hong Bang
                       Hepatoma Res 2020;6:49  http://dx.doi.org/10.20517/2394-5079.2020.39


          50         Risk factors for hepatocellular carcinoma recurrence after liver transplantation
                       Pierluigi Toniutto, Ezio Fornasiere, Elisa Fumolo, Davide Bitetto
                       Hepatoma Res 2020;6:50  http://dx.doi.org/10.20517/2394-5079.2020.40

          51         Liver imaging reporting and data system and CT/MRI diagnosis of hepatocellular carcinoma
                       Devaraju Kanmaniraja, Victoria Chernyak
                       Hepatoma Res 2020;6:51  http://dx.doi.org/10.20517/2394-5079.2020.46


          52         Global pattern and trend of liver cancer survival: a systematic review of population-based studies
                       Yu-Fei Jiang, Zhuo-Ying Li, Xiao-Wei Ji, Qiu-Ming Shen, Jia-Yi Tuo, Hui-Yun Yuan, Yong-Bing Xiang
                       Hepatoma Res 2020;6:52  http://dx.doi.org/10.20517/2394-5079.2020.47

          53         Contrast-enhanced ultrasound liver reporting and data system for hepatocellular carcinoma diagnosis
                       Alexander M. Vezeridis, Yuko Kono
                       Hepatoma Res 2020;6:53  http://dx.doi.org/10.20517/2394-5079.2020.36

          54         Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation
                       recipients with hepatocellular carcinoma - a single center retrospective study
                       Akihiko Ichida, Nobuhisa Akamatsu, Kiyoshi Hasegawa
                       Hepatoma Res 2020;6:54  http://dx.doi.org/10.20517/2394-5079.2020.59


          55         Role of imaging in management of hepatocellular carcinoma: surveillance, diagnosis, and treatment response
                       Azeez Osho, Nicole E. Rich, Amit G. Singal
                       Hepatoma Res 2020;6:55  http://dx.doi.org/10.20517/2394-5079.2020.42


          56         Can radiotherapy finally “go live” in the management of liver metastases?
                       Reggie G. John, Francis Ho, Gokula K. Appalanaido, Desiree Chen, Jeremy Tey, Yu Yang Soon, Balamurugan A.
                       Vellayappan
                       Hepatoma Res 2020;6:56  http://dx.doi.org/10.20517/2394-5079.2020.37


          57         Contrast-enhanced ultrasound of focal liver masses
                       Stephanie R. Wilson, Christina Merrill
                       Hepatoma Res 2020;6:57  http://dx.doi.org/10.20517/2394-5079.2020.48
   4   5   6   7   8   9   10   11   12   13   14